Deaths and complications following prostatectomy in 1400 men in the Northern Region of England

Thorpe, Andrew; Clearly, R.; Coles, James; Vernon, Sally; Reynolds, James M.; Neal, David E.

doi:10.1111/j.1464-410x.1994.tb09184.x

Cited by 75 publications

(40 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[4][5][6]25,26 In addition, some of the newer modalities were designed to treat the increasing number of high-risk patients.7,8 Al though all procedures claim to be minimally in vasive, the actual degree of invasiveness varies widely. Drug treatment is close to watchful wait ing,26 whereas contact laser vaporization21 and electrovaporization27,28 may be seen as modified TURPs that cause minimal bleeding.…”

Section: Commentmentioning

confidence: 99%

Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia

Muschter

Rosette

Whitfield

et al. 1996

Urology

View full text Add to dashboard Cite

Objectives. To report the initial results of treatment of outlet obstruction induced by benign prostatic hy perplasia (BPH) using interstitial laser coagulation performed with the Indigo 830 nm diode laser system. Methods. A group of 112 men with lower urinary tract symptoms caused by BPH underwent treatment with the Indigo 830 nm laser system between October 1994 and November 1995. Patients were assessed prior to treatment and at specified post-treatment intervals for symptom score, uroflow, postvoid residual, and prostate volume. Adverse events and changes in laboratory parameters were monitored at each post-treatment visit to investigate safety of the procedure. Results. Symptom score decreased from 20.9 at initial measurement to 9,6 at 3 months after procedure and 7.9 at 6 months. Uroflow rate increased from 8.0 m i l s initially to 15.2 and 14.2 mL/s at 3 and 6 months, respectively. Residual bladder volumes decreased from 105 mL initially to 59 and 38 mL at 3 and 6 months, respectively. There were no major complications (impotence, sustained incontinence, significant blood loss). Minor complications occurred in a small number of patients but were generally associated with urinary tract infection in patients with catheters. Three patients (2.7%) required retreatment and underwent transurethral resection of the prostate. Conclusions. Interstitial laser coagulation using an 830-nm diode laser system appears to be a promising new treatment, with substantial improvements in objective and subjective parameters of obstruction and a favorable side-effect profile. UROLOGY 48: 223-228, 1996.

show abstract

Section: Commentmentioning

confidence: 99%

Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia

Muschter

Rosette

Whitfield

et al. 1996

Urology

View full text Add to dashboard Cite

show abstract

“…[13,14,15,16] Although the nosocomial urinary system infection agent microorganisms show variance in the literature, the most commonly seen agent microorganism is reported as E.coli. [12][13][14][15][16]18] An increased multiple antibiotic resistance and in particular increased resistance against quinolones of E. coli is reported. [16,17] Similarly, in our study, E. Coli was the most frequently isolated bacteria, 41 agent microorganisms were isolated in the patients who developed USI.…”

Section: Discussionmentioning

confidence: 99%

“…The risk factors which would affect the postoperative complication rates for TURP are reported as prostate size, histology, prostatectomy duration, preoperative bacteriuria, catheterization, surgeries applied simultaneously, previous prostate surgery. [13,14,16,17] When we look at our study, preoperative catheter use among those factors are the significant risk factors in terms of postoperative nosocomial infection development. In the literature, existence of urinary catheter was found as the most important risk factor for the nosocomial infection.…”

Section: Discussionmentioning

confidence: 99%

Risk Factors for Urinary Tract Infections in Patients Who Underwent Transurethral Prostatectomy

Budak¹

2016

Ann Clin Anal Med

View full text Add to dashboard Cite

ÖzetAmaç: Transüretral prostat rezeksiyonu (TURP) benign prostat hiperplazisinin (BPH) cerrahi tedavisinde hala altın standarttır. Üriner sistem enfeksiyonu bu işlemin arzu edilmeyen komplikasyonlarından biridir. Bu çalışmanın amacı TURP sonrası gelişen nozokomiyal üriner sistem enfeksiyonların oluş-masından sorumlu olan risk faktörlerini incelemektir. Gereç ve Yöntem: Ocak 2008-Haziran 2009 tarihleri arası BPH tanısıyla TUR-P uygulanan yaş ortalaması 67.5±14.1 (49-87 arası) olan 175 hasta çalışmaya dahil edildi. Hastalar nozkomiyal üriner enfeksiyonu olanlar (ÜSE) ve olmayanlar şeklinde 2 gruba ayrıldı. Gruplar preoperatif PSA düzeyleri, prostat biyopsisi, operasyon süresi, rezeke edilen doku miktarı, hastanede kalış süresi ve preoperatif kataterizasyon açısından karşılaştırıldı. Bulgular: Otuzdört (%19,4) hastada nozokomiyal ÜSE saptandı. Nozokomiyal ÜSE grubunda preoperatif kataterizasyonu (p=0,01) risk faktörü açısından istatistiksel olarak anlamlı bulduk. PSA, prostat biyopsisi, operasyon süresi, hastanede kalış süresi ve rezeke edilen doku miktarıyla postoperatif nozokomiyal ÜSE arasında anlamlı bir ilişki tespit etmedik. Tartışma: BPH nedeniyle TURP planlanan kataterizasyonu olan hastalar ayrıntılı biçimde incelenmelidir. Özellikle de preoperatif dö-nemde kataterizasyonlu hastalar operasyon sonrası enfeksiyon açısından yakından takip edilmelidir. Anahtar KelimelerBenign Prostat Hiperplazisi; Transüretral Prostatektomi; Nozokomiyal Enfeksiyon Abstract Aim: Transurethral resection of prostate (TURP) is still the gold standard in the surgical treatment of benign prostatic hyperplasia (BPH). Urinary tract infection is an unwilling complication after the procedure. The aim of this study is to evaluate the risk factors which are responsable for the occurrence of nosocomial urinary system infection (NUSI) after TURP. Material and Method: A total of 175 patients with a mean age of 67.5±14.1 years ( ranged from 49 to 87 years) underwent transurehral prostatectomy for BPH in between January 2008 and June 2009. After the patients were divided two groups as NUSI and non-NUSI, Analyzse of the clinical parameters of preoperative PSA, previous prostate biopsy, operation time, resected tissue weight, hospitalization period and preoperative catheterization with the nosocomial urinary system infections was done. Results: NUSI was found in thirty-four (19.4%) patients. Preoperative catheterization (p=0.01) were found as the statistically significant risk factors in the group with nosocomial USI. There was no statistically significant correlation between the PSA, prostate biopsy, operation time, hospitalization period and resected tissue weight with the development of postoperative NUSI. Discussion: The patients with catheterization who are candidates of transurethral prostatectomy for the treatment of BPH should be examined detaily preoperatively period. Especially the patients who were preoperative catheterization should be followed up after the treatment for postoperative infection.

show abstract

“…1 However, about a quarter of men selected on the basis of symptoms and¯ow rates fail to do well after TURP 2 and in the long term, about a ®fth undergo a second operation. 3 Causes of early morbidity include peri-and postoperative bleeding requiring blood transfusion in 2 ± 5% of patients 4 and clinical manifestations of¯uid absorption occurring in 2% of cases. 5,6 Transurethral electrovaporization of the prostate (TUEVP) is a modi®cation of TURP.…”

Section: Introductionmentioning

confidence: 99%

Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results

Tizzani¹,

Casetta²,

Piana³

et al. 1999

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

Short term follow up studies on transurethral electrovaporization (TUEVP) have shown a relative low morbidity over TURP. The use of high power current has been claimed as a source of possible damage on the neuronal structures surrounding the prostate.The aims of our study were to assess longer follow up results as well as the safety of this technique.Over an 18 month mean follow up period symptom relief remained relatively stable. Postoperative dysuria was detected in a higher percentage of patients and was seen for a longer period in comparison with previous reports.Immunohistochemical staining performed using S-100 and NF monoclonal antibodies showed anatomical integrity of the prostatic neuronal ®bres surrounding the vaporization edge.In conclusion, although the effectiveness and safety of TUEVP are con®rmed by the present study, the occurrence of a signi®cant rate of long-lasting postoperative irritative symptoms must be taken into account.

show abstract

Deaths and complications following prostatectomy in 1400 men in the Northern Region of England

Cited by 75 publications

References 14 publications

Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia

Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia

Risk Factors for Urinary Tract Infections in Patients Who Underwent Transurethral Prostatectomy

Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results

Contact Info

Product

Resources

About